2006—2008年我院口服降糖药应用分析分析.PDFVIP

2006—2008 年我院口服降糖药应用分析 王伟 1 2 ，陈军辉 (1.新疆医科大学第五附属医院药剂科，乌鲁木齐 830011 ；2.新疆医科大学第六附属医院药剂科，乌鲁木齐 830002) 摘要：目的 评估我院口服降糖药的应用状况，为临床合理用药提供参考。方法 采用药物限定日剂量(DDD 值)分析方 法，统计我院 2006—2008 年口服降糖药的用药频度(DDDs)、销售金额、每日药费(DDC)等数据。结果 二甲双胍、瑞格 列奈、阿卡波糖、格列美脲、格列奇特缓释片、罗格列酮钠片的 DDDs 逐年增长，销售金额亦呈增长趋势，DDDs 排名 前 3 位的是二甲双胍、瑞格列奈、阿卡波糖；销售金额排名前 3 位的是瑞格列奈、二甲双胍、阿卡波糖。销售金额序号 与 DDDs 序号比值在 0.5~2.2 之间。结论 二甲双胍、瑞格列奈、阿卡波糖在我院口服降糖药使用中占主导地位，尤其新 品种在我院得到了广泛的应用。我院口服降糖药的使用基本合理。 关键词：口服降糖药；用药频度；药物应用分析 中图分类号：R969.3 文献标志码：B 文章编号：1007-7693(2010)13-1233-04 Analysis of Oral Hypoglycemic Drugs Used in Our Hospital from 2006 to 2008 1 2 WANG Wei , CHEN Junhui (1.Department of Pharmaceutics, Fifth Affiliated Hospital, Xinjiang Medical University, Urumqi 830011, China; 2. Department of Pharmaceutics, Sixth Affiliated Hospital, Xinjiang Medical University, Urumqi 830002, China) ABSTRACT: OBJECTIVE To evaluate the use of oral hypoglycemic drugs in our hospital in order to provide an reference for rational use of drugs in clinic. METHODS DDDs, sales volume, and daily expenses of drugs in our hospital from 2006 to 2008 were analyzed with the method of DDD analysis. RESULTS DDDs of oral hypoglycemic drugs (Metformin, Repaglinide, 作者简介：王伟，女，硕士，副主任药师 Tel:E-mail: ww7952516@126.com 中国现代应用药学2010 年 7 月第 27 卷第 13 期 Chin JMAP, 2010 July, Vol.27 No.13 ·1233 · Acarbose, Glimepiride, Gliclazide Modified Release, Rosiglitazone Sodium) increased year by year, sales volumes increased slightly. The top 3 oral hypoglycemic drugs in respect of DDDs were Metformin, Repaglinide, Acarbose; The top 3 oral hypoglycemic drugs in respect of sales volume were Repaglinide, Metformin, Acarbose. The ratio of sales volume sequencing to that of DDD